deltatrials
Active Not Recruiting PHASE1 INTERVENTIONAL 1-arm NCT06014086

Intratumoral PH-762 for Cutaneous Carcinoma

Dose Escalation Study of Neoadjuvant Intratumoral PH-762 for Cutaneous Squamous Cell Carcinoma, Melanoma, or Merkel Cell Carcinoma

Sponsor: Phio Pharmaceuticals Inc.

Conditions Malignant Melanoma of Skin Merkel Cell Carcinoma of Skin Squamous Cell Carcinoma of the Skin
Interventions PH-762
Updated 11 times since 2023 Last updated: Feb 9, 2026 Started: Nov 7, 2023 Primary completion: Dec 29, 2025 Completion: Mar 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Malignant Melanoma of Skin and Merkel Cell Carcinoma of Skin, this trial is ongoing. The trial is conducted by Phio Pharmaceuticals Inc. and has accumulated 11 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Sep 2023 – ~Dec 2023 · 3 months · monthly snapshotNot Yet Recruiting~Dec 2023 – ~Apr 2024 · 4 months · monthly snapshotRecruiting~Apr 2024 – ~Jun 2024 · 2 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotRecruiting~Feb 2025 – ~Aug 2025 · 6 months · monthly snapshotRecruiting~Aug 2025 – ~Jan 2026 · 5 months · monthly snapshotRecruiting~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshotActive Not Recruiting

Change History

11 versions recorded

  1. Feb 2026 — Present [monthly]

    Active Not Recruiting PHASE1

  2. Jan 2026 — Feb 2026 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  3. Aug 2025 — Jan 2026 [monthly]

    Recruiting PHASE1

  4. Feb 2025 — Aug 2025 [monthly]

    Recruiting PHASE1

  5. Sep 2024 — Feb 2025 [monthly]

    Recruiting PHASE1

▶ Show 6 earlier versions

  1. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  2. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE1

  3. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE1

  4. Apr 2024 — Jun 2024 [monthly]

    Recruiting PHASE1

  5. Dec 2023 — Apr 2024 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  6. Sep 2023 — Dec 2023 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Phio Pharmaceuticals Inc.
  • Prosoft Clinical
Data source: Phio Pharmaceuticals Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations